Eliezer Katz
Directeur Technique/Scientifique/R&D chez ELEDON PHARMACEUTICALS, INC.
Profil
Eliezer Katz is currently the Chief Medical Officer at Eledon Pharmaceuticals, Inc. He previously worked as the Chief Medical Officer at eGenesis, Inc. He obtained a doctorate degree from The Hebrew University Hadassah Medical School.
Postes actifs de Eliezer Katz
| Sociétés | Poste | Début |
|---|---|---|
| ELEDON PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 23/10/2023 |
Anciens postes connus de Eliezer Katz
| Sociétés | Poste | Fin |
|---|---|---|
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | - |
Formation de Eliezer Katz
| The Hebrew University Hadassah Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ELEDON PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
eGenesis, Inc.
eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Commercial Services |
